Advancing NMIBC diagnosis and treatment: Cutting-Edge Technologies and Clinical Approaches

Join leading global experts for an exclusive scientific program dedicated to optimizing clinical outcomes in Non-Muscle-Invasive Bladder Cancer (NMIBC). This specialized session will delve into the latest guidelines, visual detection advancements like NBI and PDD, and future strategies to prevent recurrence. Don't miss this opportunity to gain valuable insights from international key opinion leaders, explore precision treatment pathways, and participate in an interactive panel discussion designed to elevate patient care standards.

Clinical Background

1. Welcome and Introduction: Guidelines, challenges and strategies for optimized NMIBC diagnosis and treatment - by Dr. Gígja Gudbrandsdottir (Norway)

2. Improving Visual Detection for NMIBC Diagnosis - How NBI helps me improving clinical outcomes - Dr. Bernard H. Bochner (USA) 

3. Optimizing diagnostic strategy in NMIBC: Complementary use of NBI and PDD for precision treatment pathway - Dr. Gígja Gudbrandsdottir (Norway)

4. Preventing NMIBC recurrence: Patient care strategy and future development - Dr. Jeremy Teoh (Hong Kong)

5. Panel Discussion & Closing Remarks